Category Archives: Antipsychotic medication

New Practice Guidelines on the Use of Antipsychotics in Dementia

A new guideline from the American Psychiatric Association is designed to improve the care of patients with dementia who are exhibiting agitation or psychosis. More specifically, this guideline focuses on the judicious use of antipsychotic medications when agitation or psychosis … Continue reading

Posted in Antipsychotic medication, Dementia, Guideline | Comments Off on New Practice Guidelines on the Use of Antipsychotics in Dementia

Antipsychotic Use in Parkinson’s Disease Associated With Mortality Risk

A new study by researchers at the Perelman School of Medicine at the University of Pennsylvania, the University of Michigan Medical School, and the Philadelphia and Ann Arbor Veterans Affairs (VA) Medical Centers and suggests that antipsychotic drugs may do … Continue reading

Posted in Antipsychotic medication, Dementia, Parkinson's Disease | Comments Off on Antipsychotic Use in Parkinson’s Disease Associated With Mortality Risk

Antipsychotic Discontinuation in Recovered First-Episode Psychosis Results in Relapse

A study published in the Journal of Clinical Psychiatry evaluated the risk of symptom recurrence over 3 years after antipsychotic discontinuation in a sample of functionally recovered first-episode nonaffective psychosis (FEP) patients with schizophrenia spectrum disorder. When to discontinue antipsychotic … Continue reading

Posted in Antipsychotic medication, First episode psychosis, Psychosis, Schizophrenia | Tagged | Comments Off on Antipsychotic Discontinuation in Recovered First-Episode Psychosis Results in Relapse

AMA Moves to Ban Direct-To-Consumer Pharmaceutical Ads

According to the AMA, direct-to-consumer advertising of pharmaceuticals and medical devices drives up health care costs and should be banned. [More…]

Posted in Advertising, Antidepressant medication, Antipsychotic medication, Bipolar Depression, Bipolar Disorder, Depression, Direct-to-Consumer, Drug marketing, FDA, Health Industry, Mental health, News, Pharmaceutical Industry | Comments Off on AMA Moves to Ban Direct-To-Consumer Pharmaceutical Ads

New Study of Antipsychotic Use in Dementia

Call for guidelines for the use of antipsychotic drugs by people with dementia in nursing homes. New study suggests regular scrutiny of prescriptions and targeted education for physicians and nurses. [more…]

Posted in Antipsychotic medication, Dementia, Geriatrics, News | Comments Off on New Study of Antipsychotic Use in Dementia

Diabetes Screening Inadequate in Mentally Ill

New research shows that despite long-standing recommendations that severely mentally ill patients who take antipsychotics undergo annual screening for diabetes and other metabolic disorders, only 30% receive such screening. A recent research letter in JAMA Internal Medicine described a retrospective cohort … Continue reading

Posted in Antipsychotic medication, Bipolar Disorder, Cardiovascular, Cardiovascular Risk Factors, Diabetes, Mental health, Metabolic screening, Schizophrenia | Comments Off on Diabetes Screening Inadequate in Mentally Ill

Atypical Antipsychotic Shows Promise for New MDD Subtype

New to the diagnosis of major depressive disorder as of DSM-5 is the specifier “with mixed features.” According to DSM-5, “specifiers provide an opportunity to define a more homogeneous subgrouping of individuals with the disorder who share certain features (e.g., … Continue reading

Posted in Antipsychotic medication, Depression, Diagnosis, DSM-5, mixed features, Treatment | Comments Off on Atypical Antipsychotic Shows Promise for New MDD Subtype

Long-Acting Injectable Antipsychotic To Prevent Relapse in First Episode Schizophrenia

Research published in JAMA Psychiatry demonstrated that long-acting, injectable, second-generation antipsychotic medication has tremendous potential to bring clinical stability to persons with first-episode schizophrenia. According to the authors, “long-acting medications are rarely used following a first episode of schizophrenia.” Patients … Continue reading

Posted in Antipsychotic medication, Early intervention, Mental health, Schizophrenia | Comments Off on Long-Acting Injectable Antipsychotic To Prevent Relapse in First Episode Schizophrenia

APA Joins ‘Choosing Wisely’ Project With Cautions on Antipsychotic Prescribing

APA has released a list of cautionary principles that should be considered when prescribing antipsychotic medications, noting that they are sometimes prescribed inappropriately. [More…]

Posted in Antipsychotic medication, News | Comments Off on APA Joins ‘Choosing Wisely’ Project With Cautions on Antipsychotic Prescribing

Sixth Annual Chair Summit Begins This Week

This week a Master Class for Neuroscience Development called the Chair Summit takes place in Tampa, FL (Sept 26-28, 2013). In the early days of medical training in Kos, students, trainees and medical colleagues would gather to discuss their cases … Continue reading

Posted in Addiction, ADHD, Antipsychotic medication, Anxiety Disorders, Biomarker, Bipolar Disorder, Cardiovascular Risk Factors, Chronic Pain, CME, Dementia, Depression, Diabetes, Diagnosis, Digital medicine, Drug Development, Drugs, DSM-5, Early intervention, Education, Food, Genetics, Guideline, Imaging, Maintenance of Certification, Measurement-based care, Medical Education, Mood, MRI, Multiple sclerosis, Negative symptoms, Neuroscience, Obesity, Opioids, PET, Practice guideline, Psychosis, PTSD, Research, Schizophrenia, Smoking cessation, Social media, Stroke, Substance abuse, Transcranial magnetic stimulation, Vascular dementia | Comments Off on Sixth Annual Chair Summit Begins This Week